Siedner Mark J, Musinguzi Nicholas, Tsai Alexander C, Muzoora Conrad, Kembabazi Annet, Weiser Sheri D, Bennett John, Hunt Peter W, Martin Jeffrey N, Haberer Jessica E, Bangsberg David R
aMassachusetts General Hospital, Center for Global Health, Boston, Massachusetts, USA bMbarara University of Science and Technology, Mbarara, Uganda cChester M. Pierce MD Division of Global Psychiatry, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA dUniversity of California, San Francisco, California, USA eRagon Institute of Massachusetts General Hospital MIT and Harvard, and Harvard Medical School, Boston, Massachusetts, USA.
AIDS. 2014 Jan 14;28(2):267-71. doi: 10.1097/QAD.0000000000000136.
OBJECTIVES: Suppressive antiretroviral therapy (ART) substantially decreases HIV transmission in clinical research settings. We sought to measure the frequency and correlates of periods of transmission risk among individuals taking ART during multiple years of observation in rural, southwestern Uganda. DESIGN: Observational cohort study. METHODS: We collected sexual behavior and viral load data in a Ugandan cohort of people living with HIV/AIDS from the time of ART initiation. We defined each 90-day visit as a potential transmission period if HIV-1 RNA was more than 400 copies/ml and the participant reported sexual transmission risk behavior, defined as unprotected sexual contact with at least 1 HIV-uninfected partners or partners of unknown serostatus in the prior 90 days. RESULTS: We evaluated data from 463 individuals on ART over a median 3.5 years of observation and 5293 total study visits. During that time, over half (259, 56%) had detectable viremia or reported sexual transmission risk behavior at least once. However, only 23 (5%) had both simultaneously, at 28 (<1%) of all visits. Transmission sexual behavior was reported at 6% of visits with detectable viremia. In multivariable regression modeling, correlates of transmission risk periods included younger age, lower CD4 cell count, low household asset ownership and increased internalized stigma. CONCLUSION: Although detectable viremia and/or sexual transmission risk behavior occurred in over half of individuals, ART reduced periods of HIV transmission risk by over 90% during up to 6 years of observation time. These findings provide further support for provision of ART, along with interventions to promote long-term adherence, to reduce HIV transmission in HIV-endemic settings.
目的:在临床研究环境中,抑制性抗逆转录病毒疗法(ART)可大幅降低HIV传播。我们试图在乌干达西南部农村地区对接受ART治疗的个体进行多年观察,以测量传播风险期的频率及其相关因素。 设计:观察性队列研究。 方法:我们收集了乌干达一组艾滋病毒/艾滋病感染者从开始接受ART治疗时起的性行为和病毒载量数据。如果HIV-1 RNA超过400拷贝/毫升,且参与者报告有性传播风险行为,即在前90天内与至少1名未感染HIV的伴侣或血清学状态不明的伴侣发生无保护性行为,我们将每次90天的就诊定义为一个潜在传播期。 结果:我们评估了463名接受ART治疗个体的数据,观察时间中位数为3.5年,总共进行了5293次研究就诊。在此期间,超过一半(259人,56%)至少有一次可检测到病毒血症或报告有性传播风险行为。然而,只有23人(5%)在所有就诊中的28次(<1%)同时出现这两种情况。在可检测到病毒血症的就诊中,有6%报告了传播性行为。在多变量回归模型中,传播风险期的相关因素包括年龄较小、CD4细胞计数较低、家庭资产拥有量低以及内化耻辱感增加。 结论:虽然超过一半的个体出现了可检测到的病毒血症和/或性传播风险行为,但在长达6年的观察期内,ART将HIV传播风险期降低了90%以上。这些发现为在艾滋病流行地区提供ART以及促进长期坚持治疗以减少HIV传播的干预措施提供了进一步支持。
J Acquir Immune Defic Syndr. 2016-8-15
Int J Environ Res Public Health. 2018-5-29
J Acquir Immune Defic Syndr. 2016-4-1
J Acquir Immune Defic Syndr. 2013-7-1
N Engl J Med. 2011-7-18